RI UFLA (Universidade Federal de Lavras) >
DCA - Departamento de Ciência dos Alimentos >
DCA - Artigos publicados em periódicos >

Por favor, utilize esse identificador para citar este item ou usar como link: http://repositorio.ufla.br/jspui/handle/1/9702

Título: Fenofibrate prevents orotic acid--Induced hepatic steatosis in rats
Autor(es): Ferreira, Adaliene Versiani Matos
Parreira, Gleydes Gambogi
Porto, Laura Cristina Jardim
Mario, Érica Guihen
Delpuerto, Helen Lima
Martins, Almir Sousa
Botion, Leida Maria
Assunto: Hepatic steatosis
Lipid metabolism
Adipose tissue
Publicador: Elsevier
Data de publicação: 16-Fev-2008
Referência: FERREIRA, A. V. et al. Fenofibrate prevents orotic acid--Induced hepatic steatosis in rats. Life Sciences, [S.l.], v. 82, n. 15-16, p. 876-883, Apr. 2008.
Abstract: The experiments performed in this report were designed to investigate the mechanisms involved in the metabolic alterations associated with orotic acid-induced hepatic steatosis and the effect of fenofibrate, a stimulant of peroxisome proliferators-activated receptor alpha (PPARalpha), on these alterations. Male Wistar rats were divided into three experimental groups: 1) fed a balanced diet (C); 2) fed a balanced diet supplemented with 1% orotic acid (OA); 3) fed OA diet containing 100 mg.kg(-1) bw.day(-1) fenofibrate (OA+F), for 9 days. Administration of OA to rats induced significant increase in the hepatic total lipids content, marked microvesicular steatosis and decrease in plasma lipids concentrations compared to control group. Fenofibrate treatment prevented fatty liver induction, caused an additional reduction on plasma lipids concentrations and caused a 40% decrease in the lipogenic rate in adipose tissue. The results also showed a 40% increase in lipoprotein lipase (LPL) activity in adipose tissue from OA treated group and fenofibrate administration induced a 50% decrease in LPL activity. The liver mRNA expression of PPARalpha and ACO (acyl CoA oxidase) were 85% and 68% decreased in OA group when compared to control, respectively. Fenofibrate treatment increased the PPARalpha and ACO expressions whereas the CPT-1 (carnitine palmitoyl transferase-1) expression was not altered. Our results have shown that fenofibrate treatment decreases the hepatic lipid content induced by OA which is mediated by an important increase in fatty acid oxidation consequent to an increase in hepatic mRNA expression of PPARalpha and ACO.
URI: http://www.sciencedirect.com/science/article/pii/S002432050800074X
Idioma: en
Aparece nas coleções: DCA - Artigos publicados em periódicos

Arquivos neste Item:

Não há arquivos associados para este Item.

Itens protegidos por copyright, com todos os direitos reservados, Salvo indicação em contrário.

Mostrar estatísticas


DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard - Feedback